Patient must be NPO for at least 6 hours. Routine coagulation profile (PT/INR) must be checked. Discontinue antiplatelet and anticoagulant medications 5-7 days prior. Obtain informed consent and confirm no history of esophageal stricture or hiatal hernia larger than 2cm.
Patient to remain in recovery for 1-2 hours for vital sign monitoring. Clear liquid diet for the first 24 hours followed by soft diet for 2 weeks. Proton pump inhibitor (PPI) therapy prescribed for 8 weeks. Avoid heavy lifting and strenuous activity for 7 days. Report immediately if experiencing severe chest pain, fever, or hematemesis.
Clinical Guide: Anti-Reflux Mucosectomy (ARMS)
1. Comprehensive Introduction & Overview
Anti-Reflux Mucosectomy (ARMS) represents a transformative advancement in the endoscopic management of Gastroesophageal Reflux Disease (GERD). Traditionally, patients failing to achieve symptom control via Proton Pump Inhibitors (PPIs) were faced with a binary choice: lifelong pharmacological dependency or invasive anti-reflux surgery, such as Nissen fundoplication.
ARMS bridges this gap by utilizing endoscopic mucosal resection (EMR) techniques to reshape the gastroesophageal junction (GEJ). By creating a controlled, purposeful scar at the cardia, the procedure induces tissue contraction, effectively narrowing the gastric inlet and reinforcing the physiological barrier against acid reflux. This procedure is minimally invasive, performed under sedation or general anesthesia, and boasts a significantly faster recovery trajectory compared to laparoscopic surgical interventions.
2. Technical Specifications and Mechanism of Action
The Physiological Basis
The primary mechanism behind ARMS is the induction of "cicatricial stenosis." By removing strips of mucosa and submucosa at the gastric cardia, the healing process results in fibrosis. As the tissue heals, it contracts, effectively tightening the GEJ. This reduction in the diameter of the cardia increases the resistance to retrograde flow of gastric contents into the esophagus.
The Procedural Configuration
The procedure relies on standard EMR equipment, though specialized tools are often utilized to ensure precision:
* Endoscope: High-definition gastroscope with a transparent distal cap.
* Resection Device: Endoscopic snare (electrosurgical) or specialized suction-based EMR kits (e.g., multiband mucosectomy devices).
* Energy Source: High-frequency electrosurgical generator set to blended or coagulation current to minimize bleeding.
Procedural Steps
| Phase | Action |
|---|---|
| Marking | Identifying the squamocolumnar junction and marking the resection area. |
| Injection | Submucosal injection of saline/epinephrine to lift the mucosa and protect the muscularis propria. |
| Resection | Sequential resection of mucosa strips (usually 50–75% of the circumference). |
| Hemostasis | Systematic inspection of the resection bed and application of clips if necessary. |
3. Extensive Clinical Indications & Usage
Indications for ARMS
ARMS is specifically indicated for patients who meet the following criteria:
1. Refractory GERD: Chronic symptoms (heartburn, regurgitation) despite at least 8 weeks of optimized PPI therapy.
2. Anatomical Suitability: Patients with a hiatal hernia ≤ 2 cm. Large hiatal hernias (typically > 3 cm) generally preclude ARMS as a standalone procedure.
3. PPI Dependence: Patients desiring to discontinue daily PPI use due to long-term side effects or personal preference.
4. Absence of Severe Dysplasia: Patients must be screened to ensure no underlying Barrett’s esophagus with high-grade dysplasia or esophageal adenocarcinoma.
Patient Pre-operative Preparation
- Medication Management: Anticoagulants and antiplatelet agents must be managed in accordance with current ASGE guidelines.
- Diagnostic Workup:
- EGD: To assess the GEJ anatomy and rule out malignancy.
- Manometry: To rule out achalasia or other motility disorders.
- pH/Impedance Monitoring: To confirm pathological acid exposure.
- Fasting: Strict adherence to NPO status for at least 8 hours prior to the procedure.
4. Post-Operative Recovery and Protocol
The recovery phase is critical to ensure proper healing of the induced scar.
The Recovery Timeline
- Immediate Post-Op (0–24 hours): Monitoring for signs of perforation (fever, tachycardia, chest pain). Patient is usually discharged the same day or the following morning.
- Dietary Progression:
- Days 1–3: Clear liquid diet.
- Days 4–14: Full liquid to soft diet (avoiding coarse, spicy, or hot foods).
- Day 15+: Gradual transition to a regular diet, as tolerated.
- Medication Protocol:
- PPIs: High-dose PPIs are mandatory for at least 4–8 weeks post-procedure to prevent acid-induced ulceration of the healing site.
- Sucralfate: Often prescribed to coat the mucosa and facilitate healing.
5. Risks, Side Effects, and Contraindications
Potential Complications
While ARMS is less invasive than surgery, it remains an endoscopic procedure with inherent risks:
* Post-Procedural Pain: Substernal or epigastric discomfort is common and typically managed with analgesics.
* Esophageal Stricture: The most significant risk. Over-resection can lead to excessive scarring, requiring endoscopic dilation.
* Bleeding: Immediate or delayed (up to 2 weeks) hemorrhage from the resection site.
* Perforation: A rare but serious risk, particularly if the muscularis propria is compromised during resection.
Contraindications
- Large Hiatal Hernia (> 3 cm): The procedure is ineffective in the presence of a large hernia.
- Esophageal Motility Disorders: Patients with scleroderma or severe achalasia.
- Coagulopathy: Uncorrected bleeding diathesis.
- Severe Esophagitis: LA Grade D esophagitis may require primary management before attempting ARMS.
6. Alternative Treatments
- Laparoscopic Nissen Fundoplication (LNF): The "gold standard" for anatomy-based anti-reflux treatment. High efficacy but invasive with longer recovery.
- Transoral Incisionless Fundoplication (TIF): A purely endoscopic reconstruction of the valve. Less risk of stricture than ARMS but requires specialized equipment.
- Magnetic Sphincter Augmentation (LINX): Implantation of a magnetic ring to augment the LES. Requires surgical placement.
7. Frequently Asked Questions (FAQ)
1. Is ARMS a permanent cure for GERD?
ARMS provides a significant reduction in symptoms for most patients, but "cure" is a strong term. Long-term efficacy depends on the patient's anatomy and adherence to post-procedure lifestyle modifications.
2. How long does the procedure take?
The procedure typically takes between 30 to 60 minutes, depending on the complexity of the GEJ anatomy.
3. Will I be able to stop taking PPIs immediately?
No. PPIs are required for at least 4–8 weeks post-procedure to facilitate optimal healing of the mucosal injury.
4. What is the success rate of ARMS?
Clinical studies suggest that over 80% of patients experience significant improvement in their GERD-HRQL scores at 6–12 months post-procedure.
5. Is the procedure painful?
Post-procedure, some patients report mild chest discomfort or difficulty swallowing (dysphagia), which is usually transient and manageable with medication.
6. What are the signs of a complication I should look for?
Patients should seek immediate medical attention if they experience severe chest pain, high fever, or difficulty breathing post-procedure.
7. Can I undergo ARMS if I have Barrett’s Esophagus?
It depends on the stage of Barrett’s. ARMS is generally contraindicated if there is high-grade dysplasia or cancer, but may be considered in non-dysplastic cases after careful evaluation.
8. How do I know if I am a candidate?
Consultation with a gastroenterologist specializing in therapeutic endoscopy is required. You will need an EGD and potentially pH monitoring to confirm candidacy.
9. Is this procedure covered by insurance?
Coverage varies by region and provider. It is often considered an "emerging" procedure, so pre-authorization is almost always required.
10. What if the procedure doesn't work?
If symptoms persist, further evaluation is needed. Options include repeat endoscopy, dilation, or, in rare cases, surgical intervention (Nissen fundoplication).
8. Summary Table: ARMS vs. Surgical Fundoplication
| Feature | ARMS | Laparoscopic Fundoplication |
|---|---|---|
| Approach | Endoscopic (Transoral) | Laparoscopic (Abdominal) |
| Invasiveness | Low | Moderate/High |
| Recovery Time | 1–3 days | 2–4 weeks |
| Anesthesia | Sedation/General | General |
| Primary Risk | Stricture | Gas Bloat/Dysphagia |
Disclaimer: This guide is intended for clinical education purposes and does not replace professional medical judgment. Always refer to the latest clinical guidelines and institutional protocols when performing or advising on endoscopic procedures.